Original Article

Digestive Diseases and Sciences

, Volume 56, Issue 1, pp 244-251

Sustained Renal Response to Mycophenolate Mofetil and CNI Taper Promotes Survival in Liver Transplant Patients with CNI-Related Renal Dysfunction

  • A. KornbergAffiliated withDepartment of Surgery, Klinikum Rechts der Isar, TU MunichDepartment of General, Visceral and Vascular Surgery, FSU Jena Email author 
  • , B. KüpperAffiliated withDepartment of Surgery, Zentralklinikum Bad Berka
  • , K. ThrumAffiliated withDepartment of Surgery, Zentralklinikum Bad Berka
  • , B. KrauseAffiliated withDepartment of General, Visceral and Vascular Surgery, FSU Jena
  • , P. BüchlerAffiliated withDepartment of Surgery, Klinikum Rechts der Isar, TU Munich
  • , J. KornbergAffiliated withDepartment of General, Visceral and Vascular Surgery, FSU Jena
  • , A. SapplerAffiliated withDepartment of General, Visceral and Vascular Surgery, FSU Jena
  • , A. Altendorf-HofmannAffiliated withDepartment of General, Visceral and Vascular Surgery, FSU Jena
  • , J. WilbergAffiliated withDepartment of General, Visceral and Vascular Surgery, FSU Jena
    • , H. FriessAffiliated withDepartment of Surgery, Klinikum Rechts der Isar, TU Munich

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Aim

The aim of this trial was to evaluate the impact of conversion from a calcineurin-inhibitor (CNI)-based immunosuppressive regimen to mycophenolate mofetil (MMF) and reduced-dose CNI on long-term renal function and survival in a series of 63 liver transplant patients with CNI-induced renal dysfunction.

Methods

CNI dosage was significantly tapered after introduction of 2,000 mg MMF per day. Renal function was assessed by determination of serum creatinine levels and calculated creatinine clearance (CCl). The impact of relevant clinical parameters on renal function and survival post-conversion was analyzed by univariate and multivariate analysis.

Results

At 60 months post-conversion, mean creatinine level had significantly declined from 197.2 ± 58.3 μmol/l at baseline to 160.0 ± 76.5 μmol/l, and mean CCl has significantly increased from 38.4 ± 13.4 ml/min at baseline to 47.9 ± 21.1 ml/min (p < 0.001), respectively. Forty-six patients (73.1%) demonstrated sustained renal response to modified immunosuppression. Full-dose MMF medication (p = 0.006) and the early conversion (p = 0.02) were identified as independent predictors of persistent renal function improvement. Sustained renal response to MMF plus reduced-dose CNI was identified as the most relevant independent promoter of long-term survival (hazard ratio 6.9). Five-year survival rate post-conversion was 93.9% in renal responders and 64.3% in renal non-responders (log rank < 0.001).

Conclusions

Sustained renal response to MMF and CNI dose reduction promotes long-term survival in liver transplant patients with CNI-induced renal dysfunction.

Keywords

Liver transplantation Mycophenolate mofetil Calcineurin inhibitor Renal function Long-term survival